blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2432437

EP2432437 - DUAL AND SINGLE LAYER DOSAGE FORMS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  08.11.2013
Database last updated on 19.10.2024
Most recent event   Tooltip08.11.2013Application deemed to be withdrawnpublished on 11.12.2013  [2013/50]
Applicant(s)For all designated states
Bionex Pharmaceuticals LLC
Technology Centre of New Jersey 675 U.S. Highway One
North Brunswick, New Jersey 08902 / US
[2012/13]
Inventor(s)01 / TAN, Hock, Seng
7 Lavender Way
East Brunswick New Jersey 08816 / US
02 / CHUNG, Siew, Lian
7 Lavender Way
East Brunswick New Jersey 08816 / US
 [2012/13]
Representative(s)Minoja, Fabrizio
Bianchetti & Minoja S.r.l.
Via Plinio, 63
20129 Milano / IT
[N/P]
Former [2012/13]Minoja, Fabrizio
Bianchetti Bracco Minoja S.r.l. Via Plinio, 63
20129 Milano / IT
Application number, filing date10778085.022.04.2010
WO2010US31991
Priority number, dateUS20090216792P21.05.2009         Original published format: US 216792 P
[2012/13]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010135053
Date:25.11.2010
Language:EN
[2010/47]
Type: A2 Application without search report 
No.:EP2432437
Date:28.03.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 25.11.2010 takes the place of the publication of the European patent application.
[2012/13]
Search report(s)International search report - published on:KR24.02.2011
(Supplementary) European search report - dispatched on:EP15.11.2012
ClassificationIPC:A61F13/02, A61K9/70, A61L15/22, A61L15/44, A61M35/00
[2012/13]
CPC:
A61K47/32 (EP,US); A61K47/34 (EP,US); A61K9/006 (EP,US);
A61M35/00 (EP,US); A61P1/08 (EP); A61K9/0056 (EP,US);
A61K9/7007 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/13]
TitleGerman:ZWEI- UND EINSCHICHTIGE DOSIERFORMEN[2012/13]
English:DUAL AND SINGLE LAYER DOSAGE FORMS[2012/13]
French:FORMES PHARMACEUTIQUES BICOUCHES ET MONOCOUCHES[2012/13]
Entry into regional phase13.12.2011National basic fee paid 
13.12.2011Search fee paid 
13.12.2011Designation fee(s) paid 
13.12.2011Examination fee paid 
Examination procedure13.12.2011Examination requested  [2012/13]
15.06.2013Application deemed to be withdrawn, date of legal effect  [2013/50]
25.07.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/50]
Fees paidRenewal fee
28.03.2012Renewal fee patent year 03
25.04.2013Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2004043426  (LOHMANN THERAPIE SYST LTS [DE], et al) [Y] 1-12 * page 13, line 20 - line 29 * * abstract * * page 4 *;
 [Y]EP1980245  (CEPHALON FRANCE [FR], et al) [Y] 1-12 * paragraph [0011] * * claims 1-55 * * figure 2b *;
 [Y]WO9955312  (VIROTEX CORP [US]) [Y] 1-12 * page 17, line 10 - line 22 * * examples 38-40 * * claims 1-19 *;
 [Y]US5393528  (STAAB ROBERT J [US]) [Y] 1-12 * column 1, line 10 - line 18 * * column 2, line 34 - line 46 * * column 3, line 20 - line 25 * * column 13, line 33 - line 66 * * claims 1-24 *;
 [Y]WO0137814  (UNIV ROBERT GORDON [GB], et al) [Y] 1-12 * page 9 - page 10 * * claims 1-36 * * figure 1 *
International search[A]US2009028940  (JAHAGIRDAR HARSHAL ANIL [IN], et al);
 [A]US2003180360  (AM ENDE MARY T [US], et al);
 [A]US2004062801  (FAOUR JOAQUINA [AR], et al);
 [A]US2008248107  (PILGAONKAR PRATIBHA S [IN], et al);
 [A]US2003053962  (ZERBE HORST G [CA], et al);
 [A]US4713243  (SCHIRALDI MICHAEL T [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.